Global High-Priority Regulatory Events — February 02, 2026

03-02-2026

Replimune Group, Inc. filed a Form 8-K on 2026-02-03 reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with exhibits under Item 9.01. This is a multi-item filing, but specific details on the agreement, financial results, obligation terms, dollar values, or performance metrics are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or directional indicators are provided.

• ·Multi-item 8-K filing (Items 1.01, 2.02, 2.03, 9.01)
• ·Event date: 2026-02-03
• ·Filing AccNo: 0001104659-26-009510, Size: 262 KB
• ·Sector: NOT_DISCLOSED

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

ClearOne Inc filed a Form 8-K on 2026-02-03 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits in support. No details on the agreement terms, parties, financial impacts, or quantitative metrics are provided.

• ·AccNo: 0001753926-26-000244
• ·File Size: 250 KB
• ·Sector: NOT_DISCLOSED

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

03-02-2026

WM Technology, Inc. filed a multi-item 8-K on February 3, 2026, reporting the termination of a material definitive agreement under Item 1.02 (potentially negative) and departure, election, or appointment of directors or certain officers along with compensatory arrangements under Item 5.02 (mixed implications depending on details). The filing also includes Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No quantitative financial impacts, transaction values, or specific details on the events are disclosed.

03-02-2026

Lithium Americas Corp. filed an 8-K on 2026-02-03 disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 referencing Financial Statements and Exhibits. No specific details on the agreement, equity sales, transaction value, parties, or financial impacts are disclosed in the provided filing summary. This is a multi-item filing representing a material event by definition under SEC rules.

03-02-2026

Sable Offshore Corp. filed a Form 8-K on 2026-02-03 disclosing multiple items including Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the agreement or events are provided in the filing summary. No positive or negative performance indicators are mentioned.

03-02-2026

M Evo Global Acquisition Corp II filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties, or performance comparisons were disclosed. The filing provides structural updates typical of a SPAC-related merger process but lacks specifics on valuation or strategic rationale.

• ·AccNo: 0001213900-26-010970
• ·File Size: 1 MB
• ·Sector: not specified

03-02-2026

Bank of Hawaii Corp filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·Filing AccNo: 0000046195-26-000007
• ·Filing size: 324 KB

03-02-2026

Amneal Pharmaceuticals, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item filing indicating a significant corporate transaction, likely involving financing or debt. No specific transaction value, terms, financial metrics, positive or negative impacts, or other quantitative details are disclosed.

• ·Accession Number: 0001628280-26-004738
• ·File Size: 2 MB

03-02-2026

Broadridge Financial Solutions, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are disclosed.

03-02-2026

03-02-2026

SemiLEDs Corp filed a Form 8-K on 2026-02-03 (AccNo: 0001193125-26-034388, Size: 157 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed in the provided information.

• ·AccNo: 0001193125-26-034388
• ·Filing date: 2026-02-03

03-02-2026

Nano Dimension Ltd. filed an 8-K on February 3, 2026, reporting multiple items including entry into a material definitive agreement under Item 1.01, notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. While the material agreement could indicate strategic developments, the delisting notice raises significant compliance concerns. No specific transaction details, financial metrics, dollar values, or impacts are disclosed.

03-02-2026

BICYCLE THERAPEUTICS PLC filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or financial impacts are provided. No quantitative metrics, performance data, or scheduled events are mentioned.

• ·AccNo: 0001104659-26-009501
• ·File size: 256 KB
• ·Sector: not specified

03-02-2026

PayPal Holdings, Inc. filed an 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard multi-item filing likely related to an earnings release, but lacks detailed financial data for further analysis.

03-02-2026

Voyager Acquisition Corp., a Cayman Islands entity, filed an 8-K on 2026-02-03 (AccNo: 0001829126-26-000900, Size: 749 KB) disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event, with Item 9.01 providing financial statements and exhibits. No specific details on deal structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing information. Sector is not specified.

03-02-2026

BellRing Brands, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-004789), disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on leadership changes, financial metrics, reasons, or performance are disclosed.

03-02-2026

Marwynn Holdings, Inc. filed an 8-K on 2026-02-03 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial metrics, transaction values, or other quantitative details are disclosed in the provided filing information. This represents a material negative development with no offsetting positive factors mentioned.

03-02-2026

Magnera Corp filed an 8-K on February 3, 2026 (AccNo: 0000041719-26-000004), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or impacts are disclosed. Sector information is not specified.

03-02-2026

Venus Concept Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. This is a multi-item, mandatory filing with no specific details on the agreement's parties, terms, value, strategic rationale, or financial impacts explicitly stated. No quantitative metrics, period-over-period comparisons, or forward-looking guidance were mentioned.

03-02-2026

03-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on 2026-02-03 announcing the completion of an acquisition or disposition of assets under Item 2.01, alongside unregistered sales of equity securities under Item 3.02. The filing also covers changes in directors or certain officers including compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, deal values, parties, or performance comparisons (positive, negative, or flat) were disclosed.

03-02-2026

Agassi Sports Entertainment Corp. filed an 8-K on 2026-02-03 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are disclosed.

03-02-2026

Kyverna Therapeutics, Inc. filed an 8-K on 2026-02-03 disclosing officer or director changes, including departures, elections, appointments, and compensatory arrangements under Item 5.02. The filing also includes other events under Item 8.01 and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals, reasons, timing, or quantitative impacts are disclosed.

03-02-2026

Powerfleet, Inc. filed an 8-K on 2026-02-03 disclosing officer or director changes under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected position, appointment/resignation status, reasons, or financial impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

03-02-2026

Aptevo Therapeutics Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-034473), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, quantitative data, or performance metrics are disclosed.

03-02-2026

Ovintiv Inc. filed an 8-K on 2026-02-03 reporting the completion of an acquisition or disposition of assets under Item 2.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure in Item 7.01 and financial statements and exhibits in Item 9.01. No specific transaction details, parties, values, or financial metrics were disclosed in the provided filing summary.

03-02-2026

Walt Disney Co filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; Item 8.01 other events; and Item 9.01 financial statements and exhibits. No specific details on the officer affected, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, financial data, or scheduled events mentioned.

03-02-2026

Amprius Technologies, Inc. filed an 8-K on February 3, 2026, reporting under Item 1.02 the termination of a material definitive agreement. No additional details on the agreement's nature, parties involved, dollar value, strategic role, or financial impacts were disclosed. This event represents a material negative development by definition, with no offsetting positive metrics mentioned.

03-02-2026

Empery Digital Inc. filed a Form 8-K on February 3, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, positive or negative changes, or quantitative impacts are disclosed in the provided filing information. This multi-item filing indicates significant corporate governance and contractual developments, but lacks content to assess directionality.

03-02-2026

Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential departures, elections, appointments, or compensatory arrangements under Item 5.02. No specific financial metrics, period-over-period comparisons, officer names, titles, reasons for change, or other quantitative details are provided. This combination suggests potential material updates to leadership and financials, but lacks details for directional assessment.

03-02-2026

Applied Therapeutics, Inc. announced the completion of an acquisition or disposition of assets under Item 2.01 and a change in control of the registrant under Item 5.01, indicating a significant corporate transaction has closed. However, the filing also discloses a notice of delisting or failure to satisfy continued listing standards under Item 3.01, material modifications to rights of security holders under Item 3.03, changes in directors or officers under Item 5.02, and amendments to articles of incorporation or bylaws under Item 5.03. Financial statements and exhibits are provided under Item 9.01, but no specific transaction details or financial metrics are disclosed.

03-02-2026

NextTrip, Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, parties involved, deal terms, or performance impacts are disclosed.

03-02-2026

Hour Loop, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any financial metrics were provided in the filing summary. No positive or negative performance metrics were mentioned.

03-02-2026

Aureus Greenway Holdings Inc filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were attached. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics were disclosed.

03-02-2026

03-02-2026

StoneBridge Acquisition II Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, dates, reasons, financial terms, or quantitative details are mentioned in the filing description. No positive or negative metrics, scheduled events, or merger/acquisition specifics are provided.

03-02-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-03 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or performance metrics are provided in the filing summary. Sector is not specified.

03-02-2026

Marvion Inc. filed an 8-K on February 3, 2026 (AccNo: 0001683168-26-000688), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no quantitative data available.

03-02-2026

Black Hawk Acquisition Corp filed an 8-K on February 03, 2026 (AccNo: 0001829126-26-000910, Size: 262 KB) disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, compensation details, or quantitative metrics are provided in the filing summary. No merger, acquisition, or transaction details are mentioned.

03-02-2026

Investview, Inc. filed an 8-K on February 3, 2026, disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative metrics are disclosed in the provided filing summary. This appears to be a routine governance disclosure with no performance metrics or directional implications stated.

03-02-2026

Cardiff Lexington Corp filed a Form 8-K on 2026-02-03 under Item 3.03 disclosing material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and under Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications or amendments are provided. This is a multi-item filing focused on governance changes.

03-02-2026

Perspective Therapeutics, Inc. filed a Form 8-K on February 3, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details regarding the nature, parties, terms, or financial impact of the material agreement or other events are disclosed. The filing size is 18 MB, indicating potential attachments but no quantitative metrics provided.

03-02-2026

Applied Energetics, Inc. filed an 8-K on February 3, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 provides for financial statements and exhibits. No quantitative financial details, transaction values, or specific personnel names are disclosed.

03-02-2026

iQSTEL Inc filed an 8-K on February 3, 2026, reporting under Item 3.03 material modifications to rights of security holders and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, with Item 9.01 listing financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications or amendments are disclosed in the provided filing summary. No positive or negative performance metrics are mentioned.

03-02-2026

Bridgeline Digital, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, quantitative impacts, positive developments, or other details were disclosed in the filing summary. This event signals potential removal from a major US exchange.

03-02-2026

Mountain Lake Acquisition Corp. II filed an 8-K on 2026-02-03 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, synergies, regulatory details, or quantitative metrics are disclosed in the provided filing summary. No positive or negative performance metrics, scheduled events, or forward-looking statements are mentioned.

03-02-2026

5E Advanced Materials, Inc. filed a Form 8-K on 2026-02-03 under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events), indicating voluntary release of material nonpublic information and reporting of other material events. This is a multi-item filing with no specific details on the core event, transactions, financial metrics, or impacts disclosed in the provided summary. No quantitative data, guidance changes, or scheduled events are mentioned.

03-02-2026

Spectral AI, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, whether it was an appointment or resignation, reasons, timing, or any quantitative impacts were provided. No positive or negative metrics were mentioned.

03-02-2026

Rigel Pharmaceuticals Inc filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or terms were provided. No quantitative financial metrics, performance comparisons, or other numerical data were mentioned.

03-02-2026

Glimpse Group, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics such as compensation amounts are provided. Sector information is not specified.

03-02-2026

Piedmont Realty Trust, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED.

03-02-2026

Runway Growth Finance Corp. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the transaction, dollar values, strategic importance, or financial impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

03-02-2026

Exelon Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. This represents a standard governance event with no additional metrics provided.

03-02-2026

Ridgefield Acquisition Corp filed an 8-K on 2026-02-03 disclosing Item 3.03 Material Modifications to Rights of Security Holders, likely related to a merger/acquisition event. Item 9.01 includes Financial Statements and Exhibits. No quantitative details, parties, deal terms, or performance metrics are explicitly stated.

03-02-2026

Cheetah Net Supply Chain Service Inc. filed a Form 8-K on February 3, 2026, disclosing multiple material events under Items 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative impacts were disclosed in the provided filing summary. These governance-related disclosures indicate changes in shareholder rights, board/officer composition, corporate documents, and shareholder votes, with exhibits attached.

03-02-2026

Abpro Holdings, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the filing summary. No positive or negative metrics are mentioned.

• ·Filing Accession Number: 0001213900-26-011462
• ·File Size: 251 KB
• ·Sector: not specified

03-02-2026

Sphere Entertainment Co. filed an 8-K on February 3, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

03-02-2026

FB Financial Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. Sector information is not specified.

03-02-2026

Lam Research Corp filed an 8-K on February 3, 2026 (AccNo: 0000707549-26-000012), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or financial metrics are provided.

03-02-2026

ServiceTitan, Inc. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, terms, or financial impacts provided. No positive or negative metrics are disclosed.

03-02-2026

ThredUp Inc. filed an 8-K on 2026-02-03 disclosing Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. No specific details on the agreement, transaction parties, dollar values, strategic rationale, or financial impacts are provided in the filing summary. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

03-02-2026

Quantum Computing Inc. filed an 8-K on 2026-02-03 announcing the completion of an acquisition or disposition of assets under Item 2.01, accompanied by Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No details on deal structure, parties, valuation, strategic rationale, or financial impacts were disclosed. The filing provides limited informational disclosure without quantitative metrics or comparisons.

03-02-2026

SIFCO Industries Inc filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02, covering potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, reasons for change, effective dates, or any quantitative impacts are disclosed.

03-02-2026

Liberty Energy Inc. filed a Form 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial metrics, or impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative data available.

03-02-2026

SolarMax Technology, Inc. filed a Form 8-K on 2026-02-03 disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 indicates financial statements and exhibits are attached, likely including the agreement details. No specific transaction value, financial impacts, positive or negative metrics, or further details are disclosed in the provided filing summary.

03-02-2026

Antero Resources Corp filed an 8-K on February 3, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). However, it also reports the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), alongside other events (Item 8.01) and financial statements/exhibits (Item 9.01). No specific transaction details, parties, values, or impacts are disclosed.

03-02-2026

SIM Acquisition Corp. I filed an 8-K on February 3, 2026, announcing entry into a new Material Definitive Agreement (Item 1.01) while simultaneously disclosing the termination of a prior Material Definitive Agreement (Item 1.02), signaling a pivot in its merger strategy. The filing also covers departures, elections, or appointments of directors or certain officers along with compensatory arrangements (Item 5.02) and other events (Item 8.01). No financial terms, parties, valuations, or specific details are disclosed.

03-02-2026

Artisan Partners Asset Management Inc. filed an 8-K on February 3, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02, with exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information. All quantitative data and named entities remain NOT_DISCLOSED.

03-02-2026

Pacific Biosciences of California, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001299130-26-000012, Size: 134 KB), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data are explicitly stated in the provided filing summary. Sector is not specified.

03-02-2026

Uniti Group Inc. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details such as transaction value, terms, or financial impact are disclosed.

03-02-2026

Insulet Corp filed an 8-K on 2026-02-03 disclosing under Item 1.01 entry into a material definitive agreement, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, parties involved, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This represents a mandatory disclosure of a material event without further elaboration on positive or negative implications.

03-02-2026

ATLANTIC INTERNATIONAL CORP. filed an 8-K on 2026-02-03 disclosing an officer or director change under Item 5.02, which covers departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.

03-02-2026

Maui Land & Pineapple Co Inc filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement. No details on the nature of the agreement, transaction value, financial impacts, or strategic implications are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

• ·Filing Accession Number: 0001437749-26-002819
• ·Filing Size: 158 KB

03-02-2026

Antero Midstream Corp filed an 8-K on February 3, 2026, disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 8.01 covers other events, and Item 9.01 provides financial statements and exhibits. No specific transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed.

03-02-2026

AZZ INC filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, quantitative data, or impacts are disclosed.

03-02-2026

XMax Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001493152-26-004920, Size: 264 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement's terms, parties, value, financial impacts, or strategic context are provided.

• ·AccNo: 0001493152-26-004920
• ·File Size: 264 KB
• ·Sector: NOT_DISCLOSED

03-02-2026

Dine Brands Global, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, financial data, or performance comparisons are mentioned.

03-02-2026

VPR Brands, LP filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific details regarding the agreement's terms, parties, value, or financial impacts are provided in the filing summary. This is an informational disclosure of a material event without quantified metrics.

03-02-2026

Strive, Inc. filed a Form 8-K on 2026-02-03 reporting under Item 3.03 material modifications to the rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. No specific details regarding the nature of the modifications, amendments, or any financial metrics are disclosed. No positive or negative impacts are quantified in the available information.

03-02-2026

Viatris Inc filed an 8-K on February 3, 2026 (AccNo: 0001140361-26-003477), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

03-02-2026

Radian Group Inc filed an 8-K on 2026-02-03 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also discloses Regulation FD information (Item 7.01), other events (Item 8.01), and includes financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

03-02-2026

Dollar General Corp filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, individual involved, appointment or resignation status, reasons, and any impacts are NOT_DISCLOSED.

03-02-2026

Dominion Energy, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035749), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual involved, reason for change, timing, or any quantitative impacts are disclosed. No positive or negative metrics, financial data, or governance implications are mentioned.

03-02-2026

03-02-2026

Rent the Runway, Inc. filed an 8-K on 2026-02-03 disclosing entry into a Material Definitive Agreement under Item 1.01. Item 9.01 includes Financial Statements and Exhibits. No quantitative details, financial impacts, positive or negative metrics, or specific agreement terms are disclosed.

03-02-2026

Accel Entertainment, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

03-02-2026

OLB Group, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event signals potential removal from a U.S. exchange, negatively impacting liquidity and visibility. No financial metrics, transaction values, or other details such as reasons for delisting or future listing plans are disclosed.

03-02-2026

Churchill Capital Corp X/Cayman filed a Form 8-K on 2026-02-03 under Accession Number 0001193125-26-035805, disclosing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing per Item 3.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No financial metrics, transaction values, dollar amounts, percentages, or additional details on the delisting reasons or impacts are disclosed.

03-02-2026

TrueBlue, Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement under Item 2.03. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

03-02-2026

Scilex Holding Co filed an 8-K on February 3, 2026, reporting under Item 3.03 material modifications to rights of security holders and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative financial metrics, positive or negative changes, or specific details on the modifications or amendments are provided.

03-02-2026

Tavia Acquisition Corp. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with no specific positive or negative metrics provided. Financial statements and exhibits are included under Item 9.01. No deal structure details, valuations, or performance comparisons are disclosed.

• ·Accession Number: 0001213900-26-011558
• ·File Size: 273 KB

03-02-2026

NOCERA, INC. filed a Form 8-K on 2026-02-03 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing implications. The multi-item filing also reports changes in certifying accountant (Item 4.01), departures or appointments of directors/officers including compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

03-02-2026

WYTEC INTERNATIONAL INC filed an 8-K on 2026-02-03 disclosing a material cybersecurity incident under Item 1.05. No financial impacts, remediation details, or quantitative effects were disclosed in the provided filing summary. This mandatory disclosure highlights operational risks inherent to cybersecurity events.

03-02-2026

TREASURE GLOBAL INC filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01. The filing also reports financial statements and exhibits under Item 9.01. No specific details, financial terms, metrics, or impacts are disclosed.

03-02-2026

Reliance Global Group, Inc. filed a Form 8-K on February 3, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction values, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons available.

03-02-2026

Odyssey Health, Inc. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are provided.

03-02-2026

CERO Therapeutics Holdings, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001213900-26-011587), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No financial metrics, transaction values, or other quantitative details were disclosed. Sector not specified.

03-02-2026

HP Inc filed an 8-K on February 3, 2026, disclosing matters under Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details on leadership changes, financial metrics, governance amendments, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics are provided in the filing summary.

03-02-2026

ConnectM Technology Solutions, Inc. filed an 8-K on 2026-02-03 reporting Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No quantitative transaction details, dollar values, share counts, financial metrics, or performance comparisons are disclosed. The filing represents a multi-item disclosure of potentially strategic but dilutive events.

03-02-2026

AppTech Payments Corp. filed an 8-K on February 03, 2026, announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No specific details on transaction parties, value, structure, or financial impacts are disclosed.

03-02-2026

Cannabist Co Holdings Inc. filed an 8-K on 2026-02-03 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No specific details, dollar values, financial impacts, or metrics were provided.

03-02-2026

Sight Sciences, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035915), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, financial terms, or impacts are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or further context are mentioned.

03-02-2026

RING ENERGY, INC. filed an 8-K on 2026-02-03 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, reasons for change, or any quantitative metrics are disclosed in the provided filing information. The event is categorized as an Officer Change with no further elaboration on positive or negative governance implications.

03-02-2026

Nuveen Churchill Direct Lending Corp. filed an 8-K on 2026-02-03 disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). This is a multi-item mandatory filing with no specific transaction details, dollar values, terms, or financial impacts provided. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

03-02-2026

K2 Capital Acquisition Corp filed an 8-K on 2026-02-03 (AccNo: 0001213900-26-011603) disclosing entry into a Material Definitive Agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or performance comparisons are disclosed. Sector is not specified.

• ·Sector not specified
• ·File size: 1 MB

03-02-2026

AngioDynamics Inc filed an 8-K on 2026-02-03 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, names, reasons, or quantitative impacts were provided.